Cleared Traditional

K911310 - COROMETRICS 5566AAX NONINVASIVE BLOOD P...

K911310 is an FDA 510(k) clearance for COROMETRICS 5566AAX NONINVASIVE BLOOD P..., manufactured by Ge Medical Systems Information Technologies. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K911310 · Ge Medical Systems Information Technologies · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
84d
Days
Class 2
Risk

K911310 is an FDA 510(k) clearance for the COROMETRICS 5566AAX NONINVASIVE BLOOD PRESSURE MOD. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Ge Medical Systems Information Technologies (Wallingford, US). The FDA issued a Cleared decision on June 10, 1991 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ge Medical Systems Information Technologies devices

FDA 510(k) Submission Details - K911310

510(k) Number K911310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 18, 1991
Decision Date June 10, 1991
Days to Decision 84 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
41d faster than avg
Panel avg: 125d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K911310.
DIGITAL SPHYGMOMANOMETER MODEL UA-833
K912118 · A&D Engineering, Inc. · Aug 1991
DIGITAL SPHYGMOMANOMETER MODEL UB-211 AND 212
K912119 · A&D Engineering, Inc. · Aug 1991
CARDIOCAP CMX-104 MONITOR
K903237 · Datex Division Instrumentarium Corp. · Jul 1991
HP MODEL M1008B, NONINVASIVE BLOOD PRESSURE MODULE
K903771 · Hewlett-Packard Co. · Feb 1991
LOCAL REPORT GENERATOR
K904318 · Spacelabs, Inc. · Dec 1990
BIOCHEM 6100 NON-INVASIVE MONITOR
K903222 · Biochem International, Inc. · Sep 1990